News Impact
CPRX· last 90 days
CATALYST PHARMACEUTICALS INC
Backward-looking only. These statistics describe how the price moved after past news. They are not a prediction. Sample sizes are small, market context differs every day, and past performance does not predict future results. See methodology and disclaimer.
Bullish news (sentiment ≥ 0.3)
2articles
- Avg +24h
- —
- Avg +72h
- —
- Avg +7d
- —
Neutral news (−0.3 to 0.3)
0articles
- Avg +24h
- —
- Avg +72h
- —
- Avg +7d
- —
Bearish news (sentiment ≤ −0.3)
0articles
- Avg +24h
- —
- Avg +72h
- —
- Avg +7d
- —
Per-event price reaction · 2 events
- GlobalNewswire5/7/2026, 7:25:00 AMAngelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare DiseaseSentiment0.85Relevance100%+24h—+72h—+7d—
- SeekingAlpha5/7/2026, 6:50:27 AMAngelini Pharma to buy Catalyst Pharmaceuticals for $4.1BSentiment0.95Relevance100%+24h—+72h—+7d—
Not investment advice. See full disclaimer.